Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangoma Technologies (SANG) Cash & Equivalents (2020 - 2026)

Sangoma Technologies' Cash & Equivalents history spans 7 years, with the latest figure at $15.2 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 6.38% to $15.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $15.2 million through Mar 2026, down 6.38% year-over-year, with the annual reading at $13.5 million for FY2025, 16.86% down from the prior year.
  • Cash & Equivalents came in at $15.2 million for Q1 2026, up from $13.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $16.2 million in Q2 2024 to a low of $11.2 million in Q2 2023.
  • The 5-year median for Cash & Equivalents is $14.3 million (2025), against an average of $14.2 million.
  • Year-over-year, Cash & Equivalents crashed 42.51% in 2022 and then skyrocketed 45.49% in 2024.
  • Sangoma Technologies' Cash & Equivalents stood at $12.7 million in 2022, then fell by 12.17% to $11.2 million in 2023, then surged by 45.49% to $16.2 million in 2024, then decreased by 16.86% to $13.5 million in 2025, then rose by 12.61% to $15.2 million in 2026.
  • Per Business Quant, the three most recent readings for SANG's Cash & Equivalents are $15.2 million (Q1 2026), $13.5 million (Q2 2025), and $16.2 million (Q1 2025).